فارسی
The FDA’s approval today signifies a major advancement in the treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Breyanzi, a groundbreaking CAR-T therapy, has received its second approval, this time for its efficacy in CLL and SLL treatment. This approval is based on compelling data from clinical trials, notably the TRANSCEND CLL […]